Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 429

Similar articles for PubMed (Select 23281632)

1.

Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.

Shoji S, Inaba M, Tomosugi N, Okuno S, Ichii M, Yamakawa T, Kurihara S.

Eur J Haematol. 2013 Mar;90(3):237-44. doi: 10.1111/ejh.12067.

PMID:
23281632
2.

Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.

Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM.

Am J Kidney Dis. 1997 Dec;30(6):912-22.

PMID:
9398141
3.

Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents.

van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, Nubé MJ, Penne EL, Gaillard CA, Wetzels JF, Wiegerinck ET, Swinkels DW, Blankestijn PJ, Ter Wee PM; CONTRAST Investigators.

PLoS One. 2012;7(7):e39783. doi: 10.1371/journal.pone.0039783. Epub 2012 Jul 13.

4.

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

PMID:
20609178
5.

Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin.

Eleftheriadis T, Pissas G, Remoundou M, Filippidis G, Antoniadi G, Oustampasidou N, Liakopoulos V, Stefanidis I.

Int Urol Nephrol. 2014 Jan;46(1):161-7. doi: 10.1007/s11255-013-0497-9. Epub 2013 Jul 17.

PMID:
23860963
6.
7.

Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients.

Kalantar-Zadeh K, Lee GH, Miller JE, Streja E, Jing J, Robertson JA, Kovesdy CP.

Am J Kidney Dis. 2009 May;53(5):823-34. doi: 10.1053/j.ajkd.2008.12.040. Epub 2009 Apr 1.

8.

Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.

Ahluwalia N, Skikne BS, Savin V, Chonko A.

Am J Kidney Dis. 1997 Oct;30(4):532-41.

PMID:
9328369
9.

Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents.

Tessitore N, Girelli D, Campostrini N, Bedogna V, Pietro Solero G, Castagna A, Melilli E, Mantovani W, De Matteis G, Olivieri O, Poli A, Lupo A.

Nephrol Dial Transplant. 2010 Dec;25(12):3996-4002. doi: 10.1093/ndt/gfq321. Epub 2010 Jun 10.

10.

Variations in erythropoiesis and serum ferritin during erythropoietin therapy for anaemia of end-stage renal disease.

Barosi G, Merlo C, Palestra P, Liberato NL, Guarnone R, Di Dio F, Piazza V, Salvadeo A.

Acta Haematol. 1993;90(1):13-8.

PMID:
8237268
11.
12.
13.

Oxidative stress, inflammation and nutritional status during darbepoetin alpha treatment in peritoneal dialysis patients.

Malgorzewicz S, Lichodziejewska-Niemierko M, Lizakowski S, Liberek T, Lysiak-Szydlowska W, Rutkowski B.

Clin Nephrol. 2010 Mar;73(3):210-5.

PMID:
20178720
14.

Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency.

Brătescu LO, Bârsan L, Gârneaţă L, Stanciu A, Lipan M, Stancu SH, Mircescu G.

Int Urol Nephrol. 2014 May;46(5):1005-12. doi: 10.1007/s11255-014-0696-z. Epub 2014 Mar 29.

PMID:
24800994
15.

Long-term intravenous epoetin-alpha / darbepoetin-alpha ratio in iron-replete hemodialysis patients.

Icardi A, Sacco P, Salvatore F, Romano U.

J Nephrol. 2007 Jan-Feb;20(1):73-9.

PMID:
17347977
16.

Efficient monthly subcutaneous administration of darbepoetin in stable CAPD patients.

Theodoridis M, Passadakis P, Kriki P, Panagoutsos S, Yannatos E, Kantartzi K, Sivridis D, Vargemezis V.

Perit Dial Int. 2005 Nov-Dec;25(6):564-9.

17.

Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.

Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, Hishida A.

Am J Nephrol. 2008;28(1):115-21. Epub 2007 Oct 17.

PMID:
17943020
18.

Hepcidin and regulation of iron homeostasis in maintenance hemodialysis patients.

Sany D, Elsawy AE, Elshahawy Y.

Saudi J Kidney Dis Transpl. 2014 Sep;25(5):967-73.

19.
20.

A comprehensive vision for intravenous iron therapy.

Coyne DW.

Am J Kidney Dis. 2008 Dec;52(6 Suppl):S14-20. doi: 10.1053/j.ajkd.2008.09.003.

PMID:
19010257
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk